Management of Anemia of inflammation in the elderly

Anemia

Volumn 2012, Issue , 2012, Pages

  MacCiò, Antonio ^a   Madeddu, Clelia ^b  

^a Sirai Hospital   (Italy)

^b UNIVERSITY OF CAGLIARI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84873866589     PISSN: 20901267     EISSN: 20901275     Source Type: Journal    
DOI: 10.1155/2012/563251     Document Type: Review

References (121)

1. Guralnik J. M., Eisenstaedt R. S., Ferrucci L., Klein H. G., Woodman R. C., Prevalence of anemia in persons 65 years and older in the United States: evidence for a high rate of unexplained anemia. Blood 2004 104 8 2263 2268 2-s2.0-4944261763 10.1182/blood-2004-05-1812 (Pubitemid 39331821)
2. Denny S. D., Kuchibhatla M. N., Cohen H. J., Impact of anemia on mortality, cognition, and function in community-dwelling elderly. The American Journal of Medicine 2006 119 4 327 334 2-s2.0-33645222620 10.1016/j.amjmed.2005. 08.027
3. Izaks G. J., Westendorp R. G. J., Knook D. L., The definition of anemia in older persons. The Journal of the American Medical Association 1999 281 18 1714 1717 2-s2.0-0033549052 10.1001/jama.281.18.1714 (Pubitemid 29226481)
4. Patel K. V., Harris T. B., Faulhaber M., Angleman S. B., Connelly S., Bauer D. C., Kuller L. H., Newman A. B., Guralnik J. M., Racial variation in the relationship of anemia with mortality and mobility disability among older adults. Blood 2007 109 11 4663 4670 2-s2.0-34249663842 10.1182/blood-2006-10- 055384 (Pubitemid 46827756)
5. Penninx B. W. J. H., Pahor M., Woodman R. C., Guralnik J. M., Anemia in old age is associated with increased mortality and hospitalization. The Journals of Gerontology A 2006 61 5 474 479 2-s2.0-33646905340 (Pubitemid 43794706)
6. Zakai N. A., Katz R., Hirsch C., Shlipak M. G., Chaves P. H. M., Newman A. B., Cushman M., A prospective study of anemia status, hemoglobin concentration, and mortality in an elderly cohort: the cardiovascular health study. Archives of Internal Medicine 2005 165 19 2214 2220 2-s2.0-27644504938 10.1001/archinte.165.19.2214 (Pubitemid 41549915)
7. Peters R., Burch L., Warner J., Beckett N., Poulter R., Bulpitt C., Haemoglobin, anaemia, dementia and cognitive decline in the elderly, a systematic review. BMC Geriatrics 2008 8, article 18 2-s2.0-67650813395 10.1186/1471-2318-8-18
8. Chaves P. H. M., Ashar B., Guralnik J. M., Fried L. P., Looking at the relationship between hemoglobin concentration and prevalent mobility difficulty in older women. Should the criteria currently used to define anemia in older people be reevaluated? Journal of the American Geriatrics Society 2002 50 7 1257 1264 2-s2.0-0036068398 10.1046/j.1532-5415.2002.50313.x (Pubitemid 34774550)
9. Penninx B. W. J. H., Guralnik J. M., Onder G., Ferrucci L., Wallace R. B., Pahor M., Anemia and decline in physical performance among older persons. The American Journal of Medicine 2003 115 2 104 110 2-s2.0-0042236607 10.1016/S0002-9343(03)00263-8 (Pubitemid 37288837)
10. Atti A. R., Palmer K., Volpato S., Zuliani G., Winblad B., Fratiglioni L., Anaemia increases the risk of dementia in cognitively intact elderly. Neurobiology of Aging 2006 27 2 278 284 2-s2.0-29844431730 10.1016/j. neurobiolaging.2005.02.007 (Pubitemid 43038552)
11. Atkinson H. H., Cesari M., Kritchevsky S. B., Penninx B. W. J. H., Fried L. P., Guralnik J. M., Williamson J. D., Predictors of combined cognitive and physical decline. Journal of the American Geriatrics Society 2005 53 7 1197 1202 2-s2.0-24344491931 10.1111/j.1532-5415.2005.53362.x (Pubitemid 41632521)
12. Riva E., Tettamanti M., Mosconi P., Apolone G., Gandini F., Nobili A., Tallone M. V., Detoma P., Giacomin A., Clerico M., Tempia P., Guala A., Fasolo G., Lucca U., Association of mild anemia with hospitalization and mortality in the elderly: the Health and Anemia population-based study. Haematologica 2009 94 1 22 28 2-s2.0-58149236988 10.3324/haematol.13449
13. Ferrucci L., Balducci L., Anemia of aging: the role of chronic inflammation and cancer. Seminars in Hematology 2008 45 4 242 249 2-s2.0-52049094830 10.1053/j.seminhematol.2008.06.001
14. Ershler W. B., Chen K., Reyes E. B., Dubois R., Economic burden of patients with anemia in selected diseases. Value in Health 2005 8 6 629 638 2-s2.0-30944445958 10.1111/j.1524-4733.2005.00058.x (Pubitemid 43110277)
15. Woodman R., Ferrucci L., Guralnik J., Anemia in older adults. Current Opinion in Hematology 2005 12 2 123 128 2-s2.0-14644434442 10.1097/01.moh. 0000154030.13020.85 (Pubitemid 40315696)
16. National Health Nutrition Examination Survey,. Anthropometric Reference Data, United States. 1988-1994, http://www.cdc.gov/nchs/about/major/nhanes/
17. Pang W. W., Schrier S. L., Anemia in the elderly. Current Opinion in Hematology 2012 19 3 133 140
18. Çoban E., Timuraaolu A., Meriç M., Iron deficiency anemia in the elderly: prevalence and endoscopic evaluation of the gastrointestinal tract in outpatients. Acta Haematologica 2003 110 1 25 28 2-s2.0-17444443582 10.1159/000072410 (Pubitemid 37140400)
19. Andrès E., Fothergill H., Mecili M., Efficacy of oral cobalamin (vitamin B12) therapy. Expert Opinion on Pharmacotherapy 2010 11 2 249 256 2-s2.0-76749150406 10.1517/14656560903456053
20. Andrès E., Federici L., Serraj K., Kaltenbach G., Update of nutrient-deficiency anemia in elderly patients. European Journal of Internal Medicine 2008 19 7 488 493 2-s2.0-55649119326 10.1016/j.ejim.2008.01.016
21. Roy C. N., Anemia of inflammation. Hematology 2010 2010 276 280 2-s2.0-79955023063
22. Stadtman E. R., Protein oxidation in aging and age-related diseases. Annals of the New York Academy of Sciences 2001 928 22 38 2-s2.0-0035039021 (Pubitemid 32386064)
23. Azzi A., Davies K. J. A., Kelly F., Free radical biology-terminology and critical thinking. FEBS Letters 2004 558 1-3 3 6 2-s2.0-0842346333 10.1016/S0014-5793(03)01526-6 (Pubitemid 38167400)
24. Galaris D., Mantzaris M., Amorgianiotis C., Oxidative stress and aging: the potential role of iron. Hormones 2008 7 2 114 122 2-s2.0-47949130497
25. Dröge W., Schipper H. M., Oxidative stress and aberrant signaling in aging and cognitive decline. Aging Cell 2007 6 3 361 370 2-s2.0-34249104544 10.1111/j.1474-9726.2007.00294.x (Pubitemid 46785141)
26. Starting 2012: Sod2, DGAT1, p53, SPARC, QTL and reprogramming in aging. Aging 2012 4 3 1 10
27. Tschopp J., Mitochondria: sovereign of inflammation? European Journal of Immunology 2011 41 5 1196 1202 2-s2.0-79955161193 10.1002/eji.201141436
28. Zhou R., Yazdi A. S., Menu P., Tschopp J., A role for mitochondria in NLRP3 inflammasome activation. Nature 2011 469 7329 221 226 2-s2.0-78651393239 10.1038/nature09663
29. Gross O., Thomas C. J., Guarda G., Tschopp J., The inflammasome: an integrated view. Immunological Reviews 2011 243 1 136 151
30. Leemans J. C., Cassel S. L., Sutterwala F. S., Sensing damage by the NLRP3 inflammasome. Immunological Reviews 2011 243 1 152 162
31. Bauernfeind F., Ablasser A., Bartok E., Kim S., Schmid-Burgk J., Cavlar T., Hornung V., Inflammasomes: current understanding and open questions. Cellular and Molecular Life Sciences 2011 68 5 765 783 2-s2.0-79951578449 10.1007/s00018-010-0567-4
32. Ye S. M., Johnson R. W., Regulation of interleukin-6 gene expression in brain of aged mice by nuclear factor B. Journal of Neuroimmunology 2001 117 1-2 87 96 2-s2.0-0035796896 10.1016/S0165-5728(01)00316-2 (Pubitemid 32595496)
33. Franceschi C., Bonafè M., Valensin S., Olivieri F., De Luca M., Ottaviani E., De Benedictis G., Inflamm-aging. An evolutionary perspective on immunosenescence. Annals of the New York Academy of Sciences 2000 908 244 254 2-s2.0-0033911488 (Pubitemid 30462008)
34. de Magalhães J. P., Curado J., Church G. M., Meta-analysis of age-related gene expression profiles identifies common signatures of aging. Bioinformatics 2009 25 7 875 881 2-s2.0-63549135460 10.1093/bioinformatics/ btp073
35. Singh T., Newman A. B., Inflammatory markers in population studies of aging. Ageing Research Reviews 2011 10 3 319 329 2-s2.0-79955973916 10.1016/j.arr.2010.11.002
36. Salminen A., Huuskonen J., Ojala J., Kauppinen A., Kaarniranta K., Suuronen T., Activation of innate immunity system during aging: NF- B signaling is the molecular culprit of inflamm-aging. Ageing Research Reviews 2008 7 2 83 105 2-s2.0-40949123149 10.1016/j.arr.2007.09.002 (Pubitemid 351418294)
37. Schroder K., Zhou R., Tschopp J., The NLRP3 inflammasome: a sensor for metabolic danger? Science 2010 327 5963 296 300 2-s2.0-74549184092 10.1126/science.1184003
38. Zhou R., Tardivel A., Thorens B., Choi I., Tschopp J., Thioredoxin-interacting protein links oxidative stress to inflammasome activation. Nature Immunology 2010 11 2 136 140 2-s2.0-75649096002 10.1038/ni.1831
39. Morgan M. J., Liu Z. G., Crosstalk of reactive oxygen species and NF- B signaling. Cell Research 2011 21 1 103 115 2-s2.0-78650894319 10.1038/cr.2010.178
40. Salminen A., Kaarniranta K., Kauppinen A., Inflammaging: disturbed interplay between autophagy and inflammasomes. Aging 2012 4 3 1 10
41. Gemma C., Neuroimmunomodulation and aging. Aging and Disease 2010 1 3 169 172
42. Ershler W. B., Keller E. T., Age-associated increased interleukin-6 gene expression, late-life diseases, and frailty. Annual Review of Medicine 2000 51 245 270 2-s2.0-0034051068 10.1146/annurev.med.51.1.245 (Pubitemid 30216036)
43. Goetzl E. J., Huang M. C., Kon J., Patel K., Schwartz J. B., Fast K., Ferrucci L., Madara K., Taub D. D., Longo D. L., Gender specificity of altered human immune cytokine profiles in aging. The FASEB Journal 2010 24 9 3580 3589 2-s2.0-77956621724 10.1096/fj.10-160911
44. Ferrucci L., Semba R. D., Guralnik J. M., Ershler W. B., Bandinelli S., Patel K. V., Sun K., Woodman R. C., Andrews N. C., Cotter R. J., Ganz T., Nemeth E., Longo D. L., Proinflammatory state, hepcidin, and anemia in older persons. Blood 2010 115 18 3810 3816 2-s2.0-77952562132 10.1182/blood-2009-02-201087
45. Vanasse G. J., Berliner N., Anemia in elderly patients: an emerging problem for the 21st century. Hematology 2010 2010 271 275 2-s2.0-79955034371
46. Ferrucci L., Guralnik J. M., Bandinelli S., Semba R. D., Lauretani F., Corsi A., Ruggiero C., Ershler W. B., Longo D. L., Unexplained anaemia in older persons is characterised by low erythropoietin and low levels of pro-inflammatory markers. British Journal of Haematology 2007 136 6 849 855 2-s2.0-33847350296 10.1111/j.1365-2141.2007.06502.x (Pubitemid 46348413)
47. Testa N. G., Structure and regulation of the erythroid system at the level of progenitor cells. Critical Reviews in Oncology/Hematology 1989 9 1 17 35 2-s2.0-0024522406 (Pubitemid 19093754)
48. Ebert B. L., Bunn H. F., Regulation of the erythropoietin gene. Blood 1999 94 6 1864 1877 2-s2.0-0033568576 (Pubitemid 29430402)
49. Sherwood J. B., The chemistry and physiology of erythropoietin. Vitamins and Hormones 1984 41 161 211 2-s2.0-0021646974 (Pubitemid 15193456)
50. Semenza G. L., Hypoxia-inducible factor 1 (HIF-1) pathway. Science's STKE 2007 2007 407 cm8 2-s2.0-35148828429 10.1126/stke.4072007cm8
51. Goldwasser E., Sherwood J. B., Radioimmunoassay of erythropoietin. British Journal of Haematology 1981 48 3 359 363 2-s2.0-0019491004 (Pubitemid 11053461)
52. Price E. A., Aging and erythropoiesis: current state of knowledge. Blood Cells, Molecules, and Diseases 2008 41 2 158 165 2-s2.0-48749084366 10.1016/j.bcmd.2008.04.005
53. Ferrucci L., Balducci L., Anemia of aging: the role of chronic inflammation and cancer. Seminars in Hematology 2008 45 4 242 249 2-s2.0-52049094830 10.1053/j.seminhematol.2008.06.001
54. Makipour S., Kanapuru B., Ershler W. B., Unexplained anemia in the elderly. Seminars in Hematology 2008 45 4 250 254 2-s2.0-52049117644 10.1053/j.seminhematol.2008.06.003
55. Blick M., Sherwin S. A., Rosenblum M., Gutterman J., Phase I study of recombinant tumor necrosis factor in cancer patients. Cancer Research 1987 47 11 2986 2989 2-s2.0-0023178374 (Pubitemid 17113448)
56. Roodman G. D., Bird A., Hutzler D., Montgomery W., Tumor necrosis factor-alpha and hematopoietic progenitors: effects of tumor necrosis factor on the growth of erythroid progenitors CFU-E and BFU-E and the hematopoietic cell lines K562, HL60, and HEL cells. Experimental Hematology 1987 15 9 928 935 2-s2.0-0023610252 (Pubitemid 18072108)
57. + cells. Experimental Hematology 2002 30 11 1238 1247 2-s2.0-18644366894 10.1016/S0301-472X(02)00930-X (Pubitemid 35287576)
58. Papadaki H. A., Kritikos H. D., Valatas V., Boumpas D. T., Eliopoulos G. D., Anemia of chronic disease in rheumatoid arthritis is associated with increased apoptosis of bone marrow erythroid cells: improvement following anti-tumor necrosis factor- α antibody therapy. Blood 2002 100 2 474 482 2-s2.0-0037100511 10.1182/blood-2002-01-0136 (Pubitemid 34761109)
59. Morceau F., Dicato M., Diederich M., Pro-inflammatory cytokine-mediated anemia: regarding molecular mechanisms of erythropoiesis. Mediators of Inflammation 2009 2009 2-s2.0-77952559404 10.1155/2009/405016 405016
60. Jelkmann W., Proinflammatory cytokines lowering erythropoietin production. Journal of Interferon & Cytokine Research 1998 18 8 555 559 2-s2.0-0031821059 (Pubitemid 28391581)
61. Means R. T. Jr., Krantz S. B., Inhibition of human erythroid colony-forming units by γ interferon can be corrected by recombinant human erythropoietin. Blood 1991 78 10 2564 2567 2-s2.0-0025719887
62. Minoo P., Zadeh M. M., Rottapel R., Lebrun J. J., Ali S., A novel SHP-1/Grb2-dependent mechanism of negative regulation of cytokine-receptor signaling: contribution of SHP-1 C-terminal tyrosines in cytokine signaling. Blood 2004 103 4 1398 1407 2-s2.0-0842328827 10.1182/blood-2003-07-2617 (Pubitemid 38168655)
63. Neumcke I., Schneider B., Fandrey J., Pagel H., Effects of pro- and antioxidative compounds on renal production of erythropoietin. Endocrinology 1999 140 2 641 645 2-s2.0-0032913279 10.1210/en.140.2.641 (Pubitemid 29058195)
64. Lang F., Lang K. S., Lang P. A., Huber S. M., Wieder T., Mechanisms and significance of eryptosis. Antioxidants & Redox Signaling 2006 8 7-8 1183 1192 2-s2.0-33746810505 10.1089/ars.2006.8.1183 (Pubitemid 44182417)
65. Semba R. D., Patel K. V., Ferrucci L., Sun K., Roy C. N., Guralnik J. M., Fried L. P., Serum antioxidants and inflammation predict red cell distribution width in older women: the Women's Health and Aging Study I. Clinical Nutrition 2010 29 5 600 604 2-s2.0-77957333789 10.1016/j.clnu.2010.03.001
66. Takeda A., Toda T., Shinohara S., Mogi Y., Matsui N., Factors contributing to higher hematocrit levels in hemodialysis patients not receiving recombinant human erythropoietin. American Journal of Kidney Diseases 2002 40 1 104 109 2-s2.0-0036280662 10.1053/ajkd.2002.33918 (Pubitemid 34701217)
67. Gainsford T., Willson T. A., Metcalf D., Handman E., Mcfarlane C., Ng A., Nicola N. A., Alexander W. S., Hilton D. J., Leptin can induce proliferation, differentiation, and functional activation of hemopoietic cells. Proceedings of the National Academy of Sciences of the United States of America 1996 93 25 14564 14568 2-s2.0-0029952911 10.1073/pnas.93.25.14564 (Pubitemid 26419007)
68. Ganz T., Nemeth E., The hepcidin-ferooportin system as a therapeutic target in anemias and iron overload disorders. Hematology 2011 2011 538 542
69. Nemeth E., Tuttle M. S., Powelson J., Vaughn M. D., Donovan A., Ward D. M., Ganz T., Kaplan J., Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science 2004 306 5704 2090 2093 2-s2.0-10844258104 10.1126/science.1104742 (Pubitemid 40007660)
70. Babitt J. L., Huang F. W., Wrighting D. M., Xia Y., Sidis Y., Samad T. A., Campagna J. A., Chung R. T., Schneyer A. L., Woolf C. J., Andrews N. C., Lin H. Y., Bone morphogenetic protein signaling by hemojuvelin regulates hepcidin expression. Nature Genetics 2006 38 5 531 539 2-s2.0-33646370235 10.1038/ng1777
71. Alvarez-Hernandez X., Liceaga J., McKay I. C., Brock J. H., Induction of hypoferremia and modulation of macrophage iron metabolism by tumor necrosis factor. Laboratory Investigation 1989 61 3 319 322 2-s2.0-0024431912 (Pubitemid 19249645)
72. Torti F. M., Torti S. V., Regulation of ferritin genes and protein. Blood 2002 99 10 3505 3516 2-s2.0-0037093202 10.1182/blood.V99.10.3505 (Pubitemid 34534516)
73. Tilg H., Ulmer H., Kaser A., Weiss G., Role of IL-10 for induction of anemia during inflammation. Journal of Immunology 2002 169 4 2204 2209 2-s2.0-0037103231 (Pubitemid 34857689)
74. Andrews N. C., The iron transporter DMT1. The International Journal of Biochemistry & Cell Biology 1999 31 10 991 994 2-s2.0-0032829676 10.1016/S1357-2725(99)00065-5 (Pubitemid 29454538)
75. Soe-Lin S., Apte S. S., Mikhael M. R., Kayembe L. K., Nie G., Ponka P., Both Nramp1 and DMT1 are necessary for efficient macrophage iron recycling. Experimental Hematology 2010 38 8 609 617 2-s2.0-77954541370 10.1016/j.exphem.2010.04.003
76. Ludwiczek S., Aigner E., Theurl I., Weiss G., Cytokine-mediated regulation of iron transport in human monocytic cells. Blood 2003 101 10 4148 4154 2-s2.0-0037926880 10.1182/blood-2002-08-2459 (Pubitemid 36857898)
77. Wrighting D. M., Andrews N. C., Interleukin-6 induces hepcidin expression through STAT3. Blood 2006 108 9 3204 3209 2-s2.0-33751175421 10.1182/blood-2006-06-027631
78. Sow F. B., Alvarez G. R., Gross R. P., Satoskar A. R., Schlesinger L. S., Zwilling B. S., Lafuse W. P., Role of STAT1, NF- B, and C/EBP β in the macrophage transcriptional regulation of hepcidin by mycobacterial infection and IFN- γ Journal of Leukocyte Biology 2009 86 5 1247 1258 2-s2.0-70350738509 10.1189/jlb.1208719
79. Nicolas G., Chauvet C., Viatte L., Danan J. L., Bigard X., Devaux I., Beaumont C., Kahn A., Vaulont S., The gene encoding the iron regulatory peptide hepcidin is regulated by anemia, hypoxia, and inflammation. The Journal of Clinical Investigation 2002 110 7 1037 1044 2-s2.0-0036791486 10.1172/JCI200215686
80. Nemeth E., Rivera S., Gabayan V., Keller C., Taudorf S., Pedersen B. K., Ganz T., IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin. The Journal of Clinical Investigation 2004 113 9 1271 1276 2-s2.0-2342510407 10.1172/JCI200420945 (Pubitemid 39069926)
81. den Elzen W. P., Gussekloo J., Anaemia in older persons. The Netherlands Journal of Medicine 2011 69 6 260 267
82. Han X., Zhou D. B., Xu C. M., Yang Y., Duan M. H., Wang X., Zhang J. P., Zhao Y. Q., Shen T., Wu Y. J., The effects and mechanisms of erythropoietin on hepcidin of human monocytes. Zhonghua Xue Ye Xue Za Zhi 2011 32 7 468 472
83. Ashby D. R., Gale D. P., Busbridge M., Murphy K. G., Duncan N. D., Cairns T. D., Taube D. H., Bloom S. R., Tam F. W. K., Chapman R., Maxwell P. H., Choi P., Erythropoietin administration in humans causes a marked and prolonged reduction in circulating hepcidin. Haematologica 2010 95 3 505 508 2-s2.0-77949707023 10.3324/haematol.2009.013136
84. Ershler W. B., Artz A. S., Kandahari M. M., Recombinant erythropoietin treatment of anemia in older adults. Journal of the American Geriatrics Society 2001 49 10 1396 1397 2-s2.0-0034751760 10.1046/j.1532-5415.2001.49275.x (Pubitemid 33015223)
85. Agnihotri P., Telfer M., Butt Z., Jella A., Cella D., Kozma C. M., Ahuja M., Riaz S., Akamah J., Chronic anemia and fatigue in elderly patients: results of a randomized, double-blind, placebo-controlled, crossover exploratory study with epoetin alfa. Journal of the American Geriatrics Society 2007 55 10 1557 1565 2-s2.0-34848837102 10.1111/j.1532-5415.2007.01357.x (Pubitemid 47508491)
86. Maiese K., Chong Z. Z., Shang Y. C., Raves and risks for erythropoietin. Cytokine & Growth Factor Reviews 2008 19 2 145 155 2-s2.0-40849086204 10.1016/j.cytogfr.2008.01.004
87. Singh A. K., Szczech L., Tang K. L., Barnhart H., Sapp S., Wolfson M., Reddan D., Correction of anemia with epoetin alfa in chronic kidney disease. The New England Journal of Medicine 2006 355 20 2085 2098 2-s2.0-33750983605 10.1056/NEJMoa065485 (Pubitemid 44749317)
88. Pfeffer M. A., Burdmann E. A., Chen C. Y., Cooper M. E., De Zeeuw D., Eckardt K. U., Feyzi J. M., Ivanovich P., Kewalramani R., Levey A. S., Lewis E. F., McGill J. B., McMurray J. J. V., Parfrey P., Parving H. H., Remuzzi G., Singh A. K., Solomon S. D., Toto R., A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease. The New England Journal of Medicine 2009 361 21 2019 2032 2-s2.0-70949108082 10.1056/NEJMoa0907845
89. Maiese K., Li F., Chong Z. Z., New avenues of exploration for erythropoietin. The Journal of the American Medical Association 2005 293 1 90 95 2-s2.0-11244333356 10.1001/jama.293.1.90 (Pubitemid 40066704)
90. Lippi G., Franchini M., Favaloro E. J., Thrombotic complications of erythropoiesis-stimulating agents. Seminars in Thrombosis and Hemostasis 2010 36 5 537 549 2-s2.0-77954872334 10.1055/s-0030-1255448
91. Tjulandin S. A., Bias P., Elsässer R., Gertz B., Kohler E., Buchner A., Epoetin theta in anaemic cancer patients receiving platinum-based chemotherapy: a randomised controlled trial. Archives of Drug Information 2010 3 3 45 53 2-s2.0-78851470523 10.1111/j.1753-5174.2010.00030.x
92. Haag-Weber M., Eckardt K. U., Hörl W. H., Roger S. D., Vetter A., Roth K., Safety, immunogenicity and efficacy of subcutaneous biosimilar epoetin- α (HX575) in non-dialysis patients with renal anemia: a multi-center, randomized, double-blind study. Clinical Nephrology 2012 77 1 8 17
93. Kerkhofs L., Boschetti G., Lugini A., Stanculeanu D. L., Palomo A. G., Use of biosimilar epoetin to increase hemoglobin levels in patients with chemotherapy-induced anemia: real-life clinical experience. Future Oncology 2012 8 6 751 756
94. Bross M. H., Soch K., Smith-Knuppel T., Anemia in older persons. American Family Physician 2010 82 5 480 487 2-s2.0-77957283688
95. Baribeault D., Auerbach M., Iron replacement therapy in cancer-related anaemia. American Journal of Health-System Pharmacy 2011 68 10, supplement 2 S4 S14 2-s2.0-79957807823 10.2146/ajhp110039a
96. National Comprehensive Cancer Network,. NCCN clinical practice guidelines in oncology: cancer- and chemotherapy-induced anemia, version 1.2011, http://www.nccn.org/professionals/physician-gls/f-guidelines.asp
97. Coyne D. W., Kapoian T., Suki W., Singh A. K., Moran J. E., Dahl N. V., Rizkala A. R., Ferric gluconate is highly efficacious in anemic hemodialysis patients with high serum ferritin and low transferrin saturation: results of the Dialysis Patients' Response to IV Iron with Elevated Ferritin (DRIVE) study. Journal of the American Society of Nephrology 2007 18 3 975 984 2-s2.0-33947212276 10.1681/ASN.2006091034 (Pubitemid 46434515)
98. Jurado R. L., Iron, infections, and anemia of inflammation. Clinical Infectious Diseases 1997 25 4 888 895 2-s2.0-0030841393 (Pubitemid 27443859)
99. Macciò A., Madeddu C., Gramignano G., Mulas C., Sanna E., Mantovani G., Efficacy and safety of oral lactoferrin supplementation in combination with rHuEPO- β for the treatment of anemia in advanced cancer patients undergoing chemotherapy: open-label, randomized controlled study. The Oncologist 2010 15 8 894 902 2-s2.0-77956836074 10.1634/theoncologist.2010-0020
100. Poli M., Girelli D., Campostrini N., Maccarinelli F., Finazzi D., Luscieti S., Nai A., Arosio P., Heparin: a potent inhibitor of hepcidin expression in vitro and in vivo. Blood 2011 117 3 997 1004 2-s2.0-78751696745 10.1182/blood-2010-06-289082
101. Steinbicker A. U., Sachidanandan C., Vonner A. J., Yusuf R. Z., Deng D. Y., Lai C. S., Rauwerdink K. M., Winn J. C., Saez B., Cook C. M., Szekely B. A., Roy C. N., Seehra J. S., Cuny G. D., Scadden D. T., Peterson R. T., Bloch K. D., Yu P. B., Inhibition of bone morphogenetic protein signaling attenuates anemia associated with inflammation. Blood 2011 117 18 4915 4923 2-s2.0-79955980950 10.1182/blood-2010-10-313064
102. Fung E., Hsu J., Damoiseaux R., Ganz T., Nemeth E., Identification of hepcidin antagonists through a high throughput screening approach. The FASEB Journal 2011 24 supplement 1011.6
103. Coward J., Kulbe H., Chakravarty P., Leader D., Vassileva V., Leinster D. A., Thompson R., Schioppa T., Nemeth J., Vermeulen J., Singh N., Avril N., Cummings J., Rexhepaj E., Jirström K., Gallagher W. M., Brennan D. J., McNeish I. A., Balkwill F. R., Interleukin-6 as a therapeutic target in human ovarian cancer. Clinical Cancer Research 2011 17 18 6083 6096
104. Blagosklonny M. V., Aging: ROS or TOR. Cell Cycle 2008 7 21 3344 3354 2-s2.0-55849152355
105. Anisimov V. N., Zabezhinski M. A., Popovich I. G., Piskunova T. S., Semenchenko A. V., Tyndyk M. L., Yurova M. N., Rosenfeld S. V., Blagosklonny M. V., Rapamycin increases lifespan and inhibits spontaneous tumorigenesis in inbred female mice. Cell Cycle 2011 10 24 4230 4236
106. Majumder S., Caccamo A., Medina D. X., Benavides A. D., Javors M. A., Kraig E., Strong R., Richardson A., Oddo S., Life-long rapamycin administration ameliorates age-dependent cognitive deficits by reducing IL-1 β and NMDA signaling. Aging Cell 2012 11 2 326 335
107. Mihaylova M. M., Shaw R. J., The AMPK signalling pathway coordinates cell growth, autophagy and metabolism. Nature Cell Biology 2011 13 9 1016 1023
108. Salminen A., Kaarniranta K., AMP-activated protein kinase (AMPK) controls the aging process via an integrated signaling network. Ageing Research Review 2012 11 230 241
109. Fogarty S., Hardie D. G., Development of protein kinase activators: AMPK as a target in metabolic disorders and cancer. Biochimica et Biophysica Acta 2010 1804 3 581 591 2-s2.0-75349099919 10.1016/j.bbapap.2009.09.012
110. Recio M. C., Andújar I., Ríos J. L., Anti-inflammatory agents from plants: progress and potential. Current Medicinal Chemistry 2012 19 14 2088 2103
111. Kähkönen M. P., Hopia A. I., Vuorela H. J., Rauha J. P., Pihlaja K., Kujala T. S., Heinonen M., Antioxidant activity of plant extracts containing phenolic compounds. Journal of Agricultural and Food Chemistry 1999 47 10 3954 3962 2-s2.0-0038510421 10.1021/jf990146l (Pubitemid 29506183)
112. Qian E. W., Ge D. T., Kong S. K., Salidroside promotes erythropoiesis and protects erythroblasts against oxidative stress by up-regulating glutathione peroxidase and thioredoxin. Journal of Ethnopharmacology 2011 133 2 308 314 2-s2.0-78651400173 10.1016/j.jep.2010.09.025
113. Selmi C., Leung P. S. C., Fischer L., German B., Yang C. Y., Kenny T. P., Cysewski G. R., Gershwin M. E., The effects of Spirulina on anemia and immune function in senior citizens. Cellular & Molecular Immunology 2011 8 3 248 254 2-s2.0-79955653930 10.1038/cmi.2010.76
114. Hsu S. P., Chiang C. K., Yang S. Y., Chien C. T., N-acetylcysteine for the management of anemia and oxidative stress in hemodialysis patients. Nephron-Clinical Practice 2010 116 3 c207 c216 2-s2.0-77954184657 10.1159/000317201
115. Jurenka J. S., Anti-inflammatory properties of curcumin, a major constituent of Curcuma longa: a review of preclinical and clinical research. Alternative Medicine Review 2009 14 2 141 153 2-s2.0-67650973761
116. Perry E. K., Pickering A. T., Wang W. W., Houghton P. J., Perry N. S. L., Medicinal plants and Alzheimer's disease: from ethnobotany to phytotherapy. Journal of Pharmacy and Pharmacology 1999 51 5 527 534 2-s2.0-0032989035 10.1211/0022357991772808 (Pubitemid 29319777)
117. Aruoma O. I., Hayashi Y., Marotta F., Mantello P., Rachmilewitz E., Montagnier L., Applications and bioefficacy of the functional food supplement fermented papaya preparation. Toxicology 2010 278 1 6 16 2-s2.0-78149414013 10.1016/j.tox.2010.09.006
118. Howes M. J. R., Perry E., The role of phytochemicals in the treatment and prevention of dementia. Drugs and Aging 2011 28 6 439 468 2-s2.0-79958274796 10.2165/11591310-000000000-00000
119. Goodnough L. T., Iron deficiency syndromes and iron-restricted erythropoiesis. Transfusion 2012 52 7 1584 1592
120. Agarwal N., Prchal J. T., Erythropoietic agents and the elderly. Seminars in Hematology 2008 45 4 267 275 2-s2.0-52049124252 10.1053/j.seminhematol.2008. 06.007
121. Xie W., Du L., Diabetes is an inflammatory disease: evidence from traditional Chinese medicines. Diabetes, Obesity and Metabolism 2011 13 4 289 301 2-s2.0-79951931336 10.1111/j.1463-1326.2010.01336.x